<h3>申请 TipRanks 高级版 70% 折扣</h3>
<ul>
<li>解锁对冲基金级别的数据和强大的投资工具，以做出更聪明、更精准的决策</li>
<li>通过最新的新闻和分析保持市场领先，最大化您的投资组合潜力</li>
</ul>
<p>TOT BIOPHARM International Co. Ltd. (HK:1875) 的最新公告已发布。</p>
<p>BioDlink International Company Limited 已任命 Grand Moore Capital Limited 为其独立董事会委员会的独立财务顾问，协助吴 Xi XDC Cayman Inc. 提出的自愿有条件现金要约，以收购所有尚未被要约方持有的已发行股份，并取消所有未行使的股票期权。顾问将对要约条款是否公平合理以及股东和期权持有者的适当回应发表意见，其建议将包含在即将发布的综合文件中；公司还提醒投资者，要约的完成仍需满足条件，可能无法进行，敦促利益相关者等待委员会的建议，并在交易公司证券时保持谨慎。</p>
<p>（HK:1875）股票的最新分析师评级为持有，目标价为 HK$4.50。要查看 TOT BIOPHARM International Co. Ltd. 股票的完整分析师预测列表，请访问 HK:1875 股票预测页面。</p>
<p><strong>关于 TOT BIOPHARM International Co. Ltd. 的更多信息</strong></p>
<p>BioDlink International Company Limited 是一家在香港注册的公司，股票代码为 1875，上市于香港证券交易所。其董事会由一名执行董事、一名非执行董事和三名独立非执行董事组成，反映了受香港证券监管和收购守则约束的上市公司的典型治理结构。</p>
<p><strong>平均交易量：</strong> 1,874,849</p>
<p><strong>技术情绪信号：</strong> 买入</p>
<p><strong>当前市值：</strong> HK$3.29B</p>
<p>要对 1875 股票进行全面评估，请访问 TipRanks 的股票分析页面。</p>

药明合联

东曜药业-B

<p>BioDlink International Company Limited 已任命 Grand Moore Capital Limited 为其独立董事会委员会的独立财务顾问，负责评估 WuXi XDC Cayman Inc. 自愿有条件现金要约收购未被要约方持有的所有股份。该顾问将评估要约条款的公平性，并为股东提供建议。投资者需注意，要约的完成受制于条件。TOT BIOPHARM International Co. Ltd.（香港股票代码：1875）的最新分析师评级为持有，目标价格为港币 4.50</p>

<h3>Claim 70% Off TipRanks Premium</h3>
<div class="lb-trans"><h3>申请 TipRanks 高级版 70% 折扣</h3>
</div><ul>
<li>Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions</li>
<li>Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential</li>
</ul>
<div class="lb-trans"><ul>
<li>解锁对冲基金级别的数据和强大的投资工具，以做出更聪明、更精准的决策</li>
<li>通过最新的新闻和分析保持市场领先，最大化您的投资组合潜力</li>
</ul>
</div><p>The latest announcement is out from TOT BIOPHARM International Co. Ltd. ( (HK:1875) ).</p>
<div class="lb-trans"><p>TOT BIOPHARM International Co. Ltd. (HK:1875) 的最新公告已发布。</p>
</div><p>BioDlink International Company Limited has appointed Grand Moore Capital Limited as the independent financial adviser to its Independent Board Committee in connection with a voluntary conditional cash offer by WuXi XDC Cayman Inc. to acquire all issued shares not already owned by the offeror and to cancel all outstanding share options. The adviser will opine on whether the terms of the offers are fair and reasonable and on the appropriate response for shareholders and option holders, with its advice to be included in a forthcoming composite document; the company also cautioned investors that completion of the offers remains subject to conditions and may not proceed, urging stakeholders to await the committee’s recommendations and exercise prudence in trading the company’s securities.</p>
<div class="lb-trans"><p>BioDlink International Company Limited 已任命 Grand Moore Capital Limited 为其独立董事会委员会的独立财务顾问，协助吴 Xi XDC Cayman Inc. 提出的自愿有条件现金要约，以收购所有尚未被要约方持有的已发行股份，并取消所有未行使的股票期权。顾问将对要约条款是否公平合理以及股东和期权持有者的适当回应发表意见，其建议将包含在即将发布的综合文件中；公司还提醒投资者，要约的完成仍需满足条件，可能无法进行，敦促利益相关者等待委员会的建议，并在交易公司证券时保持谨慎。</p>
</div><p>The most recent analyst rating on (HK:1875) stock is a Hold with a HK$4.50 price target. To see the full list of analyst forecasts on TOT BIOPHARM International Co. Ltd. stock, see the HK:1875 Stock Forecast page.</p>
<div class="lb-trans"><p>（HK:1875）股票的最新分析师评级为持有，目标价为 HK$4.50。要查看 TOT BIOPHARM International Co. Ltd. 股票的完整分析师预测列表，请访问 HK:1875 股票预测页面。</p>
</div><p><strong>More about TOT BIOPHARM International Co. Ltd.</strong></p>
<div class="lb-trans"><p><strong>关于 TOT BIOPHARM International Co. Ltd. 的更多信息</strong></p>
</div><p>BioDlink International Company Limited is a Hong Kong-incorporated company listed on the Hong Kong Stock Exchange under stock code 1875. Its board comprises an executive director, a non-executive director and three independent non-executive directors, reflecting a typical governance structure for a listed firm subject to Hong Kong securities regulation and the Takeovers Code.</p>
<div class="lb-trans"><p>BioDlink International Company Limited 是一家在香港注册的公司，股票代码为 1875，上市于香港证券交易所。其董事会由一名执行董事、一名非执行董事和三名独立非执行董事组成，反映了受香港证券监管和收购守则约束的上市公司的典型治理结构。</p>
</div><p><strong>Average Trading Volume:</strong> 1,874,849</p>
<div class="lb-trans"><p><strong>平均交易量：</strong> 1,874,849</p>
</div><p><strong>Technical Sentiment Signal:</strong> Buy</p>
<div class="lb-trans"><p><strong>技术情绪信号：</strong> 买入</p>
</div><p><strong>Current Market Cap:</strong> HK$3.29B</p>
<div class="lb-trans"><p><strong>当前市值：</strong> HK$3.29B</p>
</div><p>For a thorough assessment of 1875 stock, go to TipRanks’ Stock Analysis page.</p>
<div class="lb-trans"><p>要对 1875 股票进行全面评估，请访问 TipRanks 的股票分析页面。</p>
</div>

BioDlink 任命独立顾问以应对药明合联的有条件收购提议